Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought leaders sharing insights into industry developments, sector trends and breaking news.
Psyched: MindMed’s MDMA Program For Autism, Small Pharma’s New Patent, NovaMentis’ Orphan Drug Designation
The Week In Psychedelics:
MindMed Launches MDMA Program For Social Anxiety And Autism
Digital Therapeutics And The Future Of Psychedelic Medicine
Digital health and therapeutics will play a crucial role in the future of medicine. Across medical and mental health industries, companies are realizing that the confluence of healthcare and digital platforms will be part of the future of medicine.
Can MDMA (Or Ecstasy) Improve Sexual Desire in Women? MindCure Launches Research Program To Find Out
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF), a company in the psychedelics space, is looking to bring current advancements in MDMA therapy to women’s sexual dysfunction.
Meet The Top 12 CEOs In The Psychedelics Industry
By Natan Ponieman and Javier Hasse
The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.
